FDA Clears Spirosure’s Point-of-Care Asthma Monitor
Feb 25, 2019 @ 13:51

"Spirosure Inc. has received FDA clearance of its patent-protected Fenom Pro Asthma Monitor for use by allergists, immunologists, and pulmonologists to help patients manage asthma by measuring the fraction of exhaled nitric oxide (FeNO) in their patients’ breath."

Sourced through Scoop.it from: www.mpo-mag.com

Leave a Reply